Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2009
10/06/2009US7598219 Implants comprising an osteoinductive factor and a contrast agent compatible therewith
10/06/2009US7598077 Compositions and methods for enhancing differential expression
10/06/2009US7598070 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
10/06/2009US7598067 PDEs and uses thereof
10/06/2009US7598058 Nucleic acids encoding IL13 mutants
10/06/2009US7598056 Factor VII or VIIA-like molecules
10/06/2009US7598055 N-acetylglucosaminyltransferase III expression in lower eukaryotes
10/06/2009US7598051 Ovarian carcinoma polypeptides having a specific amino acid sequence, its fusion proteins and polynucleotides encoding them; cancer vaccines
10/06/2009US7598050 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein
10/06/2009US7598048 Administering a Prokineticin 2 receptor antagonist or agonist; control internal body clock and functions
10/06/2009US7598045 Detection of the PC-LECTIN protein which correlates to the presence of an androgen-dependent prostate cancer cell; drug target and diagnostic marker for prostate cancer
10/06/2009US7598041 HIV-1 VPR interactions with mitochondrial apoptosis inducing factor and methods of using the same
10/06/2009US7597907 homoginizing an aqueous solution of a protein such as anitoxidant or detoxifying xenobiotic enzymes, with an amphiphilic polymer ( a diblock copolymer of polyethyelne glycol-lactic acid-glycolic acid copolymer) in a solvent, homoginizing emulsion with stabilizing surfactant, desolventizing; encapsulation
10/06/2009US7597904 casein-derived peptides obtained by hydrolysis of casein by a food grade bacteria containing Lactobacillus helveticusto provide a fermented dairy product containing metalloproteinases inhibitory agent
10/06/2009US7597895 Peptide or antibody that competitively inhibits binding of CSP (competence signal peptide) to Streptococcus mutans histidine kinase; endocarditis
10/06/2009US7597894 Antigen presenting cells and dendritic cells; inducing immunology response
10/06/2009US7597889 Recombinant polypeptides and nucleic acids; Graft-vs-host disease, host-vs-graft disease, organ transplant rejection, bone-marrow transplant rejection, autoimmune vasculitis, arthritis or asthma
10/06/2009US7597888 nucleic acid molecules and polypeptide molecules that encode glycoprotein VI; modulating agents in regulating a variety of cellular processes
10/06/2009US7597887 Graft-versus-host disease; inhibit secretion of Interferon-gamma (IFN-?) by lymphocytes or other immune cells in a mammal; inflammatory bowel disease is Crohn's disease, ulcerative colitis, or ileitis; KIM-1 (Kidney Injury Molecule-1)
10/06/2009US7597886 Tumor necrosis factor-gamma
10/06/2009US7597884 Hyperglycosylated polypeptide variants and methods of use
10/06/2009US7597883 Methods for promoting growth of bone, ligament, and cartilage
10/06/2009US7597875 Diaminedioxime radiometal complexes
10/06/2009CA2616580C Macrocyclic inhibitors of hepatitis c virus
10/06/2009CA2513809C Lipophilic derivatives of double-stranded ribonucleic acid
10/06/2009CA2453592C Dry hemostatic compositions and methods for their preparation
10/06/2009CA2381348C Lck-derived peptides activating ctls
10/06/2009CA2381323C Amyloid .beta. protein (globular assembly and uses thereof)
10/06/2009CA2356960C Compositions and methods for intraductal gene therapy
10/06/2009CA2328076C Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor
10/06/2009CA2321116C Pharmaceutical formulation of a didemnin compound
10/06/2009CA2310888C Monoclonal human natural antibodies
10/06/2009CA2245151C Improved process for obtaining insulin precursors having correctly bonded cystine bridges
10/06/2009CA2218129C Chimeric mcp and daf proteins with cell surface localizing domain
10/06/2009CA2207779C Carcinoma treatment
10/06/2009CA2180479C Method for treatment of obesity using prolactin modulators and diet
10/06/2009CA2159106C Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor
10/06/2009CA2120626C Method for enhancing gut absorption
10/06/2009CA2111205C Polypeptides having kinase activity, their preparation and use
10/01/2009WO2009121069A2 Compositions and methods for the preparation of nanoemulsions
10/01/2009WO2009121065A2 Modulation and repletion/enhancement of the complement system for treatment of trauma
10/01/2009WO2009120995A2 Collagen-binding synthetic peptidoglycans, preparation, and methods of use
10/01/2009WO2009120993A2 Synthetic analogs of the juxtamembrane domain of igf1r and uses thereof
10/01/2009WO2009120968A2 Coating compositions having improved performance
10/01/2009WO2009120893A2 Polypeptide-polymer conjugates and methods of use thereof
10/01/2009WO2009120837A2 Leucine-rich peptide compositions and methods for isolation
10/01/2009WO2009120831A2 Novel n-and c-terminal substituted antagonistic analogs of gh-rh
10/01/2009WO2009120810A2 Neurodegenerative disorders
10/01/2009WO2009120783A1 High affinity inhibitors of hepatitis c virus ns3/4a protease
10/01/2009WO2009120760A1 Corin for treating obesity and diabetes
10/01/2009WO2009120707A1 Uricase compositions and methods of use
10/01/2009WO2009120619A2 Nuclease compositions, methods of making and using such compositions, and systems for pulmonary delivery of such compositions
10/01/2009WO2009120562A1 Ophthalmic compositions comprising a dipeptide
10/01/2009WO2009120549A2 Methods to increase permeability of corneal epithelium and destabilize stromal collagen fibril network
10/01/2009WO2009120378A2 Methods for increasing absorption of peptides, peptidomimetics, and other gastrointestinal transport protein substrates
10/01/2009WO2009120371A2 Computationally designed inhibitors of amyloidosis
10/01/2009WO2009120307A2 Method of treating peripheral arterial disease
10/01/2009WO2009120304A1 Thrombin derived peptides for smooth muscle relaxation
10/01/2009WO2009120300A2 Method of treating degenerative diseases
10/01/2009WO2009120296A1 Treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-{2-{(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide
10/01/2009WO2009120168A1 Use of ferritin to treat iron deficiency disorders
10/01/2009WO2009120082A2 Means and methods for influencing electrical activity of cells
10/01/2009WO2009120039A2 Use of cd9 for a target protein to develop anticancer drug of solid cancers that overexpress cd9
10/01/2009WO2009119874A1 Pharmaceutical composition for treating or preventing cancer which induces dendritic cell-like differentiation of monocytes to increase anticancer immune activity
10/01/2009WO2009119792A1 GHRELIN AND DERIVATIVE THEREOF, OR THERAPEUTIC AGENT FOR CHRONIC RESPIRATORY TRACT INFECTIONS COMPRISING GROWTH HORMONE SECRETAGOGUE RECEPTOR 1a AGONIST AS ACTIVE INGREDIENT
10/01/2009WO2009119710A1 Novel antibiotic sf2896 substance, process for production thereof, and pharmaceutical composition
10/01/2009WO2009119662A1 Peptide capable of inducing autophagic cell death
10/01/2009WO2009119554A1 Promoter for bicarbonate secretion in gastrointestinal tract
10/01/2009WO2009119499A1 Stent
10/01/2009WO2009119073A1 Agent for treating skin aging and scars
10/01/2009WO2009118722A2 Methods and compositions for oral administration of proteins
10/01/2009WO2009118300A1 Treating cancer by down-regulating frizzled-4 and/or frizzled-1
10/01/2009WO2009118259A1 Ptph1 inhibitors for the treatment of alzheimer's disease
10/01/2009WO2009118191A2 Therapy for vitiligo
10/01/2009WO2009117793A1 Composition and method for the inhibition of postoperative adhesions severity
10/01/2009WO2009100127A3 Isolated brca1 peptides and method of use
10/01/2009WO2009097508A3 Methods and compositions for wound healing
10/01/2009WO2009093253A3 Compositions and methods for modulating vascular endothelial growth factor c (vegf-c) expression
10/01/2009WO2009090330A3 Use of protein 8c2 for in vitro diagnosis of mycoplasma pneumoniae infections
10/01/2009WO2009090240A3 Use of factor viia or factor viia equivalents for preventing or attenuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage (ich) in a selected subpopulation of ich patients
10/01/2009WO2009089535A3 Polypeptide vaccine and vaccination strategy against mycobacterium
10/01/2009WO2009085275A3 Use of anti-connexin polypeptide agent in combination with anti-connexin polynucleotide agent for the treatment of fibrotic conditions
10/01/2009WO2009085274A3 Use of anti-connexin polynucleotides and peptides for the treatment ofabnormal or excessive scars
10/01/2009WO2009085271A3 Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions
10/01/2009WO2009085268A3 Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions
10/01/2009WO2009080899A3 Products and methods affecting cell and tissue growth
10/01/2009WO2009080898A3 Products and methods for preventing tumour growth
10/01/2009WO2009079401A3 Compositions and methods for increasing iron absorption
10/01/2009WO2009067225A4 Boceprevir derivatives for the treatment of hcv infections
10/01/2009WO2009044383A8 Nucleic acid codifying for a utrophin transcription specific regulating protein, protein codified thereby and uses thereof
10/01/2009WO2009033809A3 Use of a peptide as a therapeutic agent
10/01/2009WO2009033791A3 Use of a peptide as a therapeutic agent
10/01/2009WO2009033730A3 Peptide gxgrgdspca as a therapeutic agent
10/01/2009WO2009033666A3 Use of parathyroid hormone ( 1-34 ) as anti-hiv agent
10/01/2009WO2008103471A9 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease
10/01/2009WO2008051306A8 Soluble tnf receptors and their use in treatment of disease
10/01/2009WO2002074916A9 Reg-like protein immunoglobulin derived proteins, compositions, methods and uses
10/01/2009US20090249502 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer; antibody or antigen-binding fragment thereof that specifically binds to a 193P1E1B protein; drug delivery
10/01/2009US20090249500 System for monitoring bacterial tumor treatment
10/01/2009US20090247733 Novel Bone Mineralization Proteins, DNA, Vectors, Expression Systems
1 ... 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 ... 3163